|
GB2145092B
(en)
|
1983-01-28 |
1988-04-07 |
Univ New York |
Protective peptide antigen
|
|
US4551433A
(en)
|
1981-05-18 |
1985-11-05 |
Genentech, Inc. |
Microbial hybrid promoters
|
|
CH660375A5
(it)
|
1983-02-08 |
1987-04-15 |
Sclavo Spa |
Procedimento per la produzione di proteine correlate alla tossina difterica.
|
|
US4755465A
(en)
|
1983-04-25 |
1988-07-05 |
Genentech, Inc. |
Secretion of correctly processed human growth hormone in E. coli and Pseudomonas
|
|
US5281532A
(en)
|
1983-07-27 |
1994-01-25 |
Mycogen Corporation |
Pseudomas hosts transformed with bacillus endotoxin genes
|
|
US4830962A
(en)
|
1984-02-09 |
1989-05-16 |
Cetus Corporation |
Recombinant diphtheria toxin fragments
|
|
ZA855232B
(en)
|
1984-07-23 |
1986-02-26 |
Univ New York |
Protective peptide antigen corresponding to plasmodium falciparum circumsporozoite protein
|
|
US5178861A
(en)
|
1984-09-12 |
1993-01-12 |
New York University |
Cross-reactive and protective epitopes of circumsporozoite proteins
|
|
ZA856655B
(en)
|
1984-09-12 |
1986-04-30 |
Univ New York |
Cross-reactive and protective epitopes of circumsporozoite proteins
|
|
US4695455A
(en)
|
1985-01-22 |
1987-09-22 |
Mycogen Corporation |
Cellular encapsulation of pesticides produced by expression of heterologous genes
|
|
US4695462A
(en)
|
1985-06-28 |
1987-09-22 |
Mycogen Corporation |
Cellular encapsulation of biological pesticides
|
|
US4709017A
(en)
|
1985-06-07 |
1987-11-24 |
President And Fellows Of Harvard College |
Modified toxic vaccines
|
|
GB8517071D0
(en)
|
1985-07-05 |
1985-08-14 |
Hoffmann La Roche |
Gram-positive expression control sequence
|
|
AU590599B2
(en)
|
1985-07-12 |
1989-11-09 |
New York University |
Immunogenic peptide antigen corresponding to plasmodium vivax circumsporozoite protein
|
|
CA1340373C
(en)
|
1986-01-28 |
1999-02-02 |
Rino Rappuoli |
Cloning and sequencing of the dna fragment which codes for the five subunits of the pertussis toxin, a hybrid plasmid containing the dna fragment and micro-organisms transformed by the hybrid plasmid and capable of expressing all or some of the subunits of the pertussis toxin
|
|
EP0252588A3
(en)
|
1986-05-12 |
1989-07-12 |
Smithkline Beecham Corporation |
Process for the isolation and purification of p. falciparum cs protein expressed in recombinant e. coli, and its use as a vaccine
|
|
US4892827A
(en)
|
1986-09-24 |
1990-01-09 |
The United States Of America As Represented By The Department Of Health And Human Services |
Recombinant pseudomonas exotoxins: construction of an active immunotoxin with low side effects
|
|
FI884485A7
(fi)
|
1987-01-30 |
1988-09-29 |
Smithkline Biologicals S A |
P. falciparumin sporotsoiitin pintaproteiinin muodostuminen hiivassa
|
|
KR0168039B1
(ko)
|
1987-09-04 |
1999-01-15 |
로버트 디. 웨스트 |
재조합 dna에서 유도한 보르데텔라 외독소 소단위체의 유사체 및 그를 포함하는 백신
|
|
US5792458A
(en)
|
1987-10-05 |
1998-08-11 |
The United States Of America As Represented By The Department Of Health And Human Services |
Mutant diphtheria toxin conjugates
|
|
GB8727489D0
(en)
|
1987-11-24 |
1987-12-23 |
Connaught Lab |
Detoxification of pertussis toxin
|
|
US5128130A
(en)
|
1988-01-22 |
1992-07-07 |
Mycogen Corporation |
Hybrid Bacillus thuringiensis gene, plasmid and transformed Pseudomonas fluorescens
|
|
AU625713B2
(en)
|
1988-02-19 |
1992-07-16 |
Microgenesys, Inc. |
Method for producing recombinant protein derived from the circumsporozoite gene of plasmodium falciparum
|
|
US5055294A
(en)
|
1988-03-03 |
1991-10-08 |
Mycogen Corporation |
Chimeric bacillus thuringiensis crystal protein gene comprising hd-73 and berliner 1715 toxin genes, transformed and expressed in pseudomonas fluorescens
|
|
GB8812214D0
(en)
|
1988-05-24 |
1988-06-29 |
Hoffmann La Roche |
Use of peptide from circumsporozoite protein of p falciparum as universally recognized t-cell epitope
|
|
US5028425A
(en)
|
1988-07-07 |
1991-07-02 |
The United States Of America As Represented By The Department Of Health And Human Services |
Synthetic vaccine against P. falciparum malaria
|
|
DE68927933T2
(de)
*
|
1988-09-02 |
1997-08-14 |
Dyax Corp |
Herstellung und auswahl von rekombinantproteinen mit verschiedenen bindestellen
|
|
US6043057A
(en)
|
1988-09-16 |
2000-03-28 |
Vitec Aktiebolag |
Recombinant systems for expression of the cholera B-sub-unit with the aid of foreign promoters and/or leader peptides
|
|
US6048728A
(en)
*
|
1988-09-23 |
2000-04-11 |
Chiron Corporation |
Cell culture medium for enhanced cell growth, culture longevity, and product expression
|
|
JPH03504082A
(ja)
|
1988-12-21 |
1991-09-12 |
スミスクライン・バイオロジカルズ |
昆虫細胞によるプラスモディウム属サーカムスポロゾイト蛋白の発現
|
|
AU5027890A
(en)
|
1989-02-10 |
1990-09-05 |
Genesit Oy |
A method for producing pertussis toxin subunits
|
|
US7232671B2
(en)
|
1989-02-15 |
2007-06-19 |
The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Pertussis toxin gene: cloning and expression of protective antigen
|
|
NZ233255A
(en)
|
1989-04-11 |
1993-02-25 |
Chiron Corp |
Plasmodium cs protein analogues lacking one or more of the repeat epitopes, and containing at least one nonrepeat flanking epitope
|
|
ES2078258T3
(es)
|
1989-04-28 |
1995-12-16 |
Sclavo Spa |
Mutantes de toxina pertussica, cepas de bordetella capaces de producir tales mutantes y su uso en el desarrollo de vacunas antipertussicas.
|
|
GB8914122D0
(en)
|
1989-06-20 |
1989-08-09 |
Wellcome Found |
Polypeptide expression
|
|
US5169760A
(en)
|
1989-07-27 |
1992-12-08 |
Mycogen Corporation |
Method, vectors, and host cells for the control of expression of heterologous genes from lac operated promoters
|
|
DE69002817T2
(de)
|
1989-11-28 |
1993-12-09 |
Wellcome Found |
Vakzine.
|
|
DE69233697T2
(de)
|
1991-03-01 |
2008-01-24 |
Dyax Corp., Cambridge |
Verfahren zur Entwicklung von bindenden Mikroproteinen
|
|
AU1762092A
(en)
|
1991-04-01 |
1992-11-02 |
United States of America, as represented by the Secretary, U.S. Department of Commerce, The |
Circumsporozoite protein of plasmodium reichenowi and vaccine for human malaria
|
|
US5935580A
(en)
|
1992-04-21 |
1999-08-10 |
Institut Pasteur |
Recombinant mutants for inducing specific immune responses
|
|
DE69313134T2
(de)
|
1992-06-25 |
1998-02-26 |
Smithkline Beecham Biolog |
Adjuvantien enthaltende impfstoffzusammensetzung
|
|
DK0616034T3
(da)
|
1993-03-05 |
2005-02-21 |
Wyeth Corp |
Plasmid til fremstilling af CRM-protein og diphtheria toxin
|
|
DK0725653T3
(da)
|
1993-10-05 |
2004-10-11 |
Celltech Pharmaceuticals Ltd |
Vaccinepræparater
|
|
GB9406492D0
(en)
|
1994-03-31 |
1994-05-25 |
Isis Innovation |
Malaria peptides
|
|
US20040214157A1
(en)
|
1994-06-29 |
2004-10-28 |
Simon C. Burton |
Chromatographic resins and methods for using same
|
|
US5652348A
(en)
|
1994-09-23 |
1997-07-29 |
Massey University |
Chromatographic resins and methods for using same
|
|
EP0785276A4
(en)
|
1994-09-29 |
2002-01-09 |
Ajinomoto Kk |
MODIFICATION OF A PEPTIDE AND A PROTEIN
|
|
US5932714A
(en)
|
1995-02-23 |
1999-08-03 |
Connaught Laboratories Limited |
Expression of gene products from genetically manipulated strains of Bordetella
|
|
SE9600590D0
(sv)
|
1996-02-19 |
1996-02-19 |
Pharmacia Biotech Ab |
Sätt för kromatografisk separation av peptider och nukleinsyra samt ny högaffin jonbytesmatris
|
|
GB9616351D0
(en)
|
1996-08-02 |
1996-09-11 |
Smithkline Beecham Biolog |
Vaccine composition
|
|
EP2298900A1
(en)
|
1996-09-17 |
2011-03-23 |
Novartis Vaccines and Diagnostics, Inc. |
Compositions and methods for treating intracellular diseases
|
|
US7393630B2
(en)
|
1997-12-16 |
2008-07-01 |
Novartis Vaccines And Diagnostics, Inc. |
Use of microparticles combined with submicron oil-in-water emulsions
|
|
HUP0200302A2
(en)
|
1999-02-18 |
2002-05-29 |
Rmf Dictagene Sa |
Malaria vaccine
|
|
GB9904582D0
(en)
|
1999-02-26 |
1999-04-21 |
Nycomed Imaging As |
Process
|
|
US6942866B2
(en)
|
2000-08-16 |
2005-09-13 |
Apovia, Inc. |
Malaria immunogen and vaccine
|
|
AUPR011700A0
(en)
|
2000-09-14 |
2000-10-05 |
Austin Research Institute, The |
Composition comprising immunogenic virus sized particles (VSP)
|
|
US7781186B2
(en)
|
2000-09-25 |
2010-08-24 |
The United States Of America As Represented By The Secretary Of The Army |
Screening methods using normal human liver cell line
|
|
AU2001293074A1
(en)
|
2000-09-25 |
2002-04-08 |
Walter Reed Army Institute Of Research |
Human liver cell line
|
|
US7363166B2
(en)
*
|
2001-03-30 |
2008-04-22 |
Council Of Scientific & Industrial Research |
Computational method for the identification of candidate proteins useful as anti-infectives
|
|
SE0104353D0
(sv)
|
2001-12-19 |
2001-12-19 |
Amersham Biosciences Ab |
Separation method
|
|
AU2003299527A1
(en)
|
2002-06-17 |
2004-06-07 |
Jimmy D. Ballard |
Mutant of clostridium difficile toxin b and methods of use
|
|
US20040067880A1
(en)
|
2002-10-04 |
2004-04-08 |
Kuo Macus Tien |
Prodrug therapy of liver diseases using receptor-mediated delivery of malarial circumsporozoite protein as a carrier
|
|
US9453251B2
(en)
|
2002-10-08 |
2016-09-27 |
Pfenex Inc. |
Expression of mammalian proteins in Pseudomonas fluorescens
|
|
US8232255B2
(en)
|
2002-10-23 |
2012-07-31 |
Glaxosmithkline Biologicals S.A. |
Methods for vaccinating against malaria
|
|
EP1573012B1
(en)
|
2002-12-17 |
2011-11-30 |
Crucell Holland B.V. |
Recombinant viral-based malaria vaccines
|
|
US7670631B2
(en)
|
2003-03-12 |
2010-03-02 |
ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. |
Method for the prevention of malaria infection of humans by hepatocyte growth factor antagonists
|
|
US8399217B2
(en)
|
2003-03-14 |
2013-03-19 |
Brookhaven Science Associates, Llc |
High density growth of T7 expression strains with auto-induction option
|
|
EP1692282B1
(en)
|
2003-11-19 |
2012-08-08 |
Pfenex, Inc. |
Improved protein expression systems in auxotrophic Pseudomonas fluorescens
|
|
BRPI0416807A
(pt)
|
2003-11-21 |
2007-01-09 |
Dow Global Technologies Inc |
sistemas de expressão aperfeiçoados com secreção de sistema sec
|
|
WO2005063805A1
(en)
|
2003-12-23 |
2005-07-14 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Antibodies against the amino terminus region of circumsporozoite protein prevent the onset of malaria infection
|
|
KR101183720B1
(ko)
|
2004-01-16 |
2012-09-17 |
다우 글로벌 테크놀로지스 엘엘씨 |
슈도모나스 플루오레센스에서의 포유류 단백질의 발현
|
|
CN101031655A
(zh)
|
2004-07-26 |
2007-09-05 |
陶氏环球技术公司 |
通过株工程改进蛋白表达的方法
|
|
JP2008510465A
(ja)
|
2004-08-20 |
2008-04-10 |
ケイエムティー ヒパテック インコーポレイテッド |
キメラヒト肝臓を有するマラリア動物モデル
|
|
GB0420634D0
(en)
|
2004-09-16 |
2004-10-20 |
Glaxosmithkline Biolog Sa |
Vaccines
|
|
US7790186B2
(en)
|
2005-01-18 |
2010-09-07 |
The United States Of America As Represented By The Secretary Of The Army |
Plasmodium vivax hybrid circumsporozoite protein and vaccine
|
|
EP1754717A1
(en)
|
2005-08-19 |
2007-02-21 |
Université de Lausanne |
Antigenic peptides and their use
|
|
EP2264058A3
(en)
|
2005-09-30 |
2011-03-23 |
Seattle Biomedical Research |
Plasmodium liver stage antigens
|
|
US7749519B2
(en)
|
2005-12-09 |
2010-07-06 |
Kim Lee Sim |
Unique DNA and polypeptide sequences based on the circumsporozoite protein of Plasmodium vivax
|
|
KR20090018799A
(ko)
|
2006-05-30 |
2009-02-23 |
다우 글로벌 테크놀로지스 인크. |
코돈 최적화 방법
|
|
KR101491867B1
(ko)
|
2007-01-31 |
2015-02-10 |
피페넥스 인크. |
증가된 발현을 위한 박테리아 리더 서열
|
|
US9580719B2
(en)
|
2007-04-27 |
2017-02-28 |
Pfenex, Inc. |
Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
|
|
US9394571B2
(en)
|
2007-04-27 |
2016-07-19 |
Pfenex Inc. |
Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
|
|
CL2008002361A1
(es)
|
2007-08-13 |
2009-08-07 |
Glaxosmithkline Biologicals Sa |
Uso de un antigeno derivado de la proteina circumesporozoito (cs) de plasmodium falciparum que se expresa en la etapa preeritrocitica de la infeccion por malaria para tratar bebes contra la malaria.
|
|
WO2009114202A2
(en)
|
2008-03-14 |
2009-09-17 |
The United States Of America As Represented By The Secretary Of The Navy |
Vaccine and immunization method using plasmodium antigen 2
|
|
WO2010008764A1
(en)
|
2008-06-23 |
2010-01-21 |
Dow Global Technologies Inc. |
Pseudomonas fluorescens strains for production of extracellular recombinant protein
|
|
EP2350130B1
(en)
|
2008-10-31 |
2018-10-03 |
Wyeth LLC |
Purification of acidic proteins using ceramic hydroxyapatite chromatography
|
|
US8063193B2
(en)
|
2009-03-27 |
2011-11-22 |
Abbott Laboratories |
Nucleotide and amino acid sequences encoding an exported protein 1 derived from Plasmodium vivax and uses thereof
|
|
MX2012010148A
(es)
|
2010-03-04 |
2013-01-22 |
Pfenex Inc |
Metodo para producir proteinas de interferon recombinantes solubles sin desnaturalizacion.
|
|
WO2011126811A2
(en)
|
2010-03-30 |
2011-10-13 |
Pfenex Inc. |
High level expression of recombinant toxin proteins
|
|
DK2385107T3
(en)
*
|
2010-05-03 |
2016-12-12 |
Pasteur Institut |
Lentiviral vector-based immunological compounds against malaria
|
|
BR112012027828A2
(pt)
|
2010-05-03 |
2016-08-09 |
Genentech Inc |
composição de matéria, artigo de fabricação e método de redução da viscosidade de uma formulação contendo proteína e de preparação de uma formulação aquosa contendo proteína
|
|
WO2012154199A1
(en)
|
2010-10-18 |
2012-11-15 |
The Government Of The United States, As Represented By The Secretary Of The Army |
Soluble recombinant plasmodium falciparum circumsporozoite protein
|
|
US9169304B2
(en)
|
2012-05-01 |
2015-10-27 |
Pfenex Inc. |
Process for purifying recombinant Plasmodium falciparum circumsporozoite protein
|